Comment on "A Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder"'

被引：0
|
作者：
Wang, Chenxi [1 ]
Tian, Huichuan [1 ]
Shang, Jin [2 ]
机构：
[1] Macau Univ Sci & Technol, Fac Chinese Med, Taipa 999078, Macao, Peoples R China
[2] Hubei Univ Tradit Chinese Med, Sch Pharm, Wuhan 430065, Peoples R China
来源：
CNS DRUGS | 2025年 / 39卷 / 02期
关键词：
D O I：
10.1007/s40263-024-01152-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 50 条
  • [31] Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
    Klein, Pavel
    Aboumatar, Sami
    Brandt, Christian
    Dong, Fang
    Krauss, Gregory L.
    Mizne, Sarah
    Sanchez-Alvarez, Juan Carlos
    Steinhoff, Bernhard J.
    Villanueva, Vicente
    NEUROLOGY, 2022, 99 (10) : E989 - E998
  • [32] An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
    Gahan Pandina
    Stuart Kushner
    Keith Karcher
    Magali Haas
    Child and Adolescent Psychiatry and Mental Health, 6 (1)
  • [33] Vortioxetine (Lu AA21004) 15 and 20 mg/day: open-label long-term safety and tolerability in major depressive disorder
    Filippov, G.
    Christens, P. F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S325 - S325
  • [34] Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis
    Komatsu, Norio
    Kirito, Keita
    Shimoda, Kazuya
    Ishikawa, Takayuki
    Ohishi, Kohshi
    Ohyashiki, Kazuma
    Takahashi, Naoto
    Okada, Hikaru
    Amagasaki, Taro
    Yonezu, Toshio
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (03) : 309 - 317
  • [35] Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis
    Norio Komatsu
    Keita Kirito
    Kazuya Shimoda
    Takayuki Ishikawa
    Kohshi Ohishi
    Kazuma Ohyashiki
    Naoto Takahashi
    Hikaru Okada
    Taro Amagasaki
    Toshio Yonezu
    Koichi Akashi
    International Journal of Hematology, 2017, 105 : 309 - 317
  • [36] Long-term efficacy/safety of adjunctive eslicarbazepine acetate:open-label extension study in adults with focal seizure
    Biraben, A.
    Grinnell, T.
    Pereira, A.
    Ikedo, F.
    Moreira, J.
    Gama, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 480 - 480
  • [37] Long-term Efficacy and Safety of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures: Open-label Extension of a Randomized Clinical Study
    Klein, Pavel
    Krauss, Gregory
    Aboumatar, Sami
    Kamin, Marc
    NEUROLOGY, 2020, 94 (15)
  • [38] Long-Term Efficacy of Adjunctive Cariprazine in Patients With MDD: Results From an Open-Label 26-Week Safety Study
    Masand, Prakash
    Vieta, Eduard
    Waraich, Simranpreet
    Kramer, Ken
    Kerolous, Majid
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 263 - 264
  • [39] Efficacy and Safety of Adjunctive Brexpiprazole 2 mg in Major Depressive Disorder: A Phase 3, Randomized, Placebo-Controlled Study in Patients With Inadequate Response to Antidepressants
    Thase, Michael E.
    Youakim, James M.
    Skuban, Aleksandar
    Hobart, Mary
    Augustine, Carole
    Zhang, Peter
    McQuade, Robert D.
    Carson, William H.
    Nyilas, Margaretta
    Sanchez, Raymond
    Eriksson, Hans
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (09) : 1224 - +
  • [40] Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan
    Inoue, Yushi
    Ohtsuka, Yoko
    EPILEPSY RESEARCH, 2015, 113 : 90 - 97
12345